A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects

NCT02252731 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of FG-4592
Healthy Subjects

Interventions

DRUG: Warfarin
DRUG: FG-4592

Sponsor

Astellas Pharma Europe B.V.

Collaborators

[object Object]